{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:41:13Z","timestamp":1790174473760,"version":"4.1.0"},"reference-count":15,"publisher":"Hindawi Limited","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1034,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Ther"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1111\/j.1529-8019.2012.01522.x","type":"journal-article","created":{"date-parts":[[2012,12,4]],"date-time":"2012-12-04T21:16:20Z","timestamp":1354655780000},"page":"615-618","source":"Crossref","is-referenced-by-count":11,"title":["Should we continue to indicate meglumine antimoniate as first-line treatment for cutaneous leishmaniasis in Tunisia"],"prefix":"10.1155","volume":"25","author":[{"given":"Rym Benmously","family":"Mlika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam Ben","family":"Hamida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houda","family":"Hammami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salima Ben","family":"Jannet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talel","family":"Badri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Fenniche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e7af","family":"Mokhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2012,12,4]]},"reference":[{"key":"10.1111\/j.1529-8019.2012.01522.x-BIB0001|dth1522-cit-0001","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaad.2009.06.088","article-title":"New World cutaneous leishmaniasis: updated review of current and future diagnosis and treatment","volume":"63","author":"Mitropoulos","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01522.x-BIB0002|dth1522-cit-0002","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tmaid.2006.09.004","article-title":"Cutaneous leishmaniasis treatment","volume":"5","author":"Minodiera","year":"2007","journal-title":"Travel Med Infect Dis"},{"key":"10.1111\/j.1529-8019.2012.01522.x-BIB0003|dth1522-cit-0003","first-page":"499","article-title":"Effets ind\u00e9sirables du traitement syst\u00e9mique de la leishmaniose cutan\u00e9e par Glucantime\u00ae: exp\u00e9rience tunisienne","volume":"68","author":"Benmously Mlika","year":"2008","journal-title":"Med Trop"},{"issue":"1","key":"10.1111\/j.1529-8019.2012.01522.x-BIB0004|dth1522-cit-0004","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.medmal.2004.07.032","article-title":"Glucantime\u00ae injection: benefit versus toxicity","volume":"35","author":"Masmoudi","year":"2005","journal-title":"M\u00e9decine et Maladies Infectieuses"},{"key":"10.1111\/j.1529-8019.2012.01522.x-BIB0005|dth1522-cit-0005","first-page":"9","article-title":"Les effets ind\u00e9sirables du glucantime\u00ae par voie g\u00e9n\u00e9rale, dans le traitement de la leishmaniose cutan\u00e9e : a propos de 15 cas","volume":"88","author":"Ezzine Sebai","year":"2010","journal-title":"Tunis Med"},{"issue":"4","key":"10.1111\/j.1529-8019.2012.01522.x-BIB0006|dth1522-cit-0006","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.annder.2007.10.003","article-title":"Glucantime\u00ae reaction with fatal outcome following treatment of cutaneous leishmaniasis","volume":"135","author":"Hajlaoui","year":"2008","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/j.1529-8019.2012.01522.x-BIB0007|dth1522-cit-0007","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1086\/341406","article-title":"A randomized, doubleblind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel","volume":"35","author":"Wortmann","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1529-8019.2012.01522.x-BIB0008|dth1522-cit-0008","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/clinids\/21.3.710","article-title":"Pancreatitis necrosis following treatment of leishmaniasis with sodium stibiogluconate","volume":"21","author":"McBride","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1111\/j.1529-8019.2012.01522.x-BIB0009|dth1522-cit-0009","first-page":"513","article-title":"Evaluation of meglumine antimoniate effects on liver, kidney and pancreas function tests in patients with cutaneous leishmaniasis","volume":"17","author":"Kashani","year":"2007","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01522.x-BIB0010|dth1522-cit-0010","doi-asserted-by":"crossref","first-page":"916","DOI":"10.47102\/annals-acadmedsg.V37N11p916","article-title":"Electrocardiographic changes in patients with cutaneous leishmaniasis treated with systemic glucantime","volume":"37","author":"Sadeghian","year":"2008","journal-title":"Ann Acad Med Singapore"},{"key":"10.1111\/j.1529-8019.2012.01522.x-BIB0011|dth1522-cit-0011","doi-asserted-by":"crossref","unstructured":"Buffet P Leishmaniose cutan\u00e9e 2008","DOI":"10.1016\/S0246-0319(08)45220-2"},{"key":"10.1111\/j.1529-8019.2012.01522.x-BIB0012|dth1522-cit-0012","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clindermatol.2006.05.008","article-title":"Cutaneous leishmaniasis","volume":"25","author":"Bailey","year":"2007","journal-title":"Clin Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01522.x-BIB0013|dth1522-cit-0013","doi-asserted-by":"crossref","first-page":"e432","DOI":"10.1371\/journal.pntd.0000432","article-title":"WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study","volume":"3","author":"Ben Salah","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1111\/j.1529-8019.2012.01522.x-BIB0014|dth1522-cit-0014","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1529-8019.2011.01424.x","article-title":"Lupoid leishmaniasis of the nose responding well to cryotherapy","volume":"24","author":"Benmously Mlika","year":"2011","journal-title":"Dermatol Ther"},{"key":"10.1111\/j.1529-8019.2012.01522.x-BIB0015|dth1522-cit-0015","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jaad.2007.12.032","article-title":"Efficacy of a weekly cryotherapy regimen to treat Leishmania major cutaneous leishmaniasis","volume":"58","author":"Mosleh","year":"2008","journal-title":"J Am Acad Dermatol"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1529-8019.2012.01522.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1529-8019.2012.01522.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T12:56:40Z","timestamp":1687870600000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1529-8019.2012.01522.x"}},"subtitle":["Treatment of cutaneous leishmaniasis in Tunisia"],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1529-8019.2012.01522.x","relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}